Back to results
US 2025/0144095 A1Published application
Compositions and methods for treatment of connective tissue disorders
AssigneeThe Johns Hopkins University
InventorsHarry C. Dietz, Caitlin J. Bowen
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to compositions and methods for treating vascular Ehlers Danlos Syndrome and associated connective tissue disorders.
Claims24
A method of treating a connective tissue disorder, comprising:
- administering a therapeutically effective amount of an agent which modulates endothelin receptor activation, expression or function, and/or inhibits endothelin-1 (ET1) expression or binding to the endothelin receptor (EDNRA/B), thereby treating the connective tissue disorder.
A method of treating a vascular Ehlers-Danlos Syndrome in a subject in need thereof, the method comprising:
- administering to the subject an effective amount of bosentan or a pharmaceutically acceptable salt thereof.
A method of treating a vascular Ehlers-Danlos Syndrome in a subject in need thereof, the method comprising:
- administering to the subject an effective amount of a small molecule endothelin receptor antagonist.
A method of treating a vascular Ehlers-Danlos Syndrome in a subject in need thereof, the method comprising:
- administering to the subject an effective amount of sitaxentan, ambrisentan, macitentan and/or tezosentan.
24-25. (canceled)
Dependencies are inferred from the claim text.